Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Dysplasia 1Sexually Transmitted Diseases, Viral 1Head and Neck Neoplasms 1

Interventions

Imiquimod 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Flow Cytometry 2Conization 2Colposcopy 2Biopsy 2poly ICLC 1motexafin lutetium 1human papillomavirus vaccine, TA 1Zoledronic Acid 1Vaccines, DNA 1Vaccines 1Transcription Activator-Like Effector Nucleases 1Sodium Chloride 1Polymerase Chain Reaction 1Photochemotherapy 1Microarray Analysis 1Interferon alpha-2 1Immunohistochemistry 1Hysterectomy 1Fluorescent Antibody Technique 1Fenofibrate 1Curcumin 1Chemoradiotherapy 1CRISPR-Associated Protein 9 1Blood Specimen Collection 11-phenyl-3,3-dimethyltriazene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Uterine Cervical Dysplasia × Vaccines, DNA × Clear all
NCT00988559 2018-07-09

Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Completed
132 enrolled 7 charts
Gynecologic

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡